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Abstract  
Biomaterials are the materials used to restore or replace functions in body tissues and are continuously or occasionally in 
contact with body fluids. Today, biomaterials are being used for wound dressing to soft and heard tissue repairs. In this review, 
we present a brief elucidation of biomaterials that are being developed for engineering tissues including biocompatible metals, 
ceramics, polymers and hydrogels. Surgical implant made up of stainless steel, titanium alloys are some of the widely 
accepted metallic alloys in tissue engineering treatment. Along with these metals, bioceramics made up of hydroxyapatite 
(HA) and Tricalcium phosphate (TCP) are analogous to the inorganic constituents of hard tissues of vertebrates. In recent 
years, hydrophilic biodegradable fibers with nanometer range have attracted great attention due to their non-immunogenic, 
non-toxic and bioresorbable nature.            
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INTRODUCTION 
 
     Regenerative medicine is a new multidisciplinary approach to 
restore the damaged tissue or organs in the body, either by stem 
cells or progenitor cells transplantation or by encouraging 
endogenous precursor cells. The main essence of tissue 
engineering/ regenerative medicine portray the use of cells together 
with natural or synthetic extracellular  materials in developing 
implants (Scaffold) to restore the damaged organs or tissues. It is 
evident that selection of scaffold is vital to facilitate the cells to 
behave in required manner to produce tissues or organs of our 
interest [1]. The ideas of using biological substitutes to repair or 
replace damaged tissues were discussed even in earlier records. As 
per “The Book of Genesis” Adam was the first donor to donate a rib 
to fashion Eve [2]. Physicians in antique India developed the skin 
grafts for cosmetic surgeries as early as 800 B.C. However, Tissue 
engineering had to wait until progress in the modern surgery. Figure 
1 illustrates the transplantation milestones in the western world. 
 
Fig 1. Major breakthroughs in organ transplantation in western world. * Denotes 
this transplantation is first time in this world. (Source: Fox R. C & Swazey, 1992) 
Significance of Biomaterials in Regenerative Medicine  
 
     Till to date, organ or tissue transplantation is like 'robbing 
Peter to pay Paul'. That is, tissue defects due to accidents, diseases, 
trauma and congenital defects are repaired by transferring healthy 
donor organs or tissues as an autograft, isograft, allograft and 
xenograft [3]. Although these solutions have resulted in great pace in 
increasing patient survival and quality of life, there are inherent 
limitations. In case of autograft, volume of donor tissue that can be 
harvested is dependent on blood supply and the need to avoid 
visceral injuries. Allografts and xenografts own the risks of immune 
rejection and transmission of infectious disease [4]. In addition to 
these limitations, there is presently a growing donor availability crisis 
which is well explained in Figure2.  
 
Fig 2. Overall deaths occurring while patients waiting for organ transplantation. 
(Source: 1996 Annual Report of the U. S. Scientific Registry for Transplant 
Recipients and the Organ Procurement) 
 
     Shortage of tissues and organs availability for transplantation 
led to the emergence of discipline biomaterials in tissue engineering. 
A well-designed three-dimensional scaffold is one of the primary 
tools to guide tissue formation in vitro and in vivo. Boundaries in 
medicine are changing rapidly from utilizing synthetic implants and 
tissue grafts to a tissue engineering approach that uses bio-
degradable porous material scaffolds integrated with biological cells 
or molecules to regenerate tissues or organs [5]. In this regard, the 
selection of scaffold material is very important to facilitate the cells to 
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behave in the desired manner to generate tissues and organs of our 
requirement. 
 
Essential Features of biomaterials 
 
a) It must be biocompatible, avoid transplant rejection by host 
immune system. 
b) It must have excellent surface properties to allow the cells to 
adhere, proliferate and migrate in to the scaffold. 
c) Scaffold material must possess controlled biodegradability to aid 
reconstruction of new tissues. 
d) The implant designed must exhibit sufficient mechanical 
properties to maintain the structure and function of the implant 
immediately after transplantation. 
e) Scaffolds must hold the structural and functional properties of 
extra cellular matrix which have the ability to transfer 
biomolecular signals between cells. 
 
Classes of Biomaterials 
 
     In general, materials used in regenerative medicine are 
classified in to, Class I materials those that do not directly in contact 
with the tissues; Class II materials are those that contact 
occasionally to the tissue; and Class III materials are those that are 
constantly in contact with the tissues [6]. Class III materials are also 
entitled as biomaterials and are further divided into 3 categories 
according to their biological interface with the body tissue as well as 
immune system. Bio-inert materials which do not produce any 
immunological reactions but retain their structure in the body. 
Bioactive materials demonstrate biological function and finally, 
biodegradable that are dissolved in body and replaced by 
regenerated tissues [7].    
 
Table 1. Classification of Materials in Tissue engineering applications 
    
Class I Do not directly contact the body tissue 
Class II Contact intermittently to the tissues 
Class III Biomaterials 
Bioinert No Immunological reaction 
Bioactive Mimic the natural tissue 
Biodegradable Completely absorbed in the tissues 
 
     Biodegradable biomaterials have the potential to induce the 
biological dysfunction in vivo. The interface between the material and 
tissue is the key area where the biological disturbances are created. 
To restore the tissue defects, the in vivo and in vitro studies of the 
released substances from material surface are indispensible in 
determining the biological characters of the implant material. The 
implant material should not inhibit the biological functions of the host 
tissues [8].   
 
Non Biodegradable Metallic Implants 
 
     Metals have quite attractive features in the area of bone 
tissue engineering including superior fracture toughness, high 
strength to weight ratio and high ductility [9].  Stainless steel is the 
first metallic implant that was widely accepted as bone fixation plates, 
screws, etc since early 19th century. However, metals have some 
intrinsic problems when used as tissue engineering implants. These 
metals typically not biologically active, meaning they don’t support 
osteoinduction (stimulate osteoprogenitor cells) and osteoconduction 
(facilitates out spread of bone cells over the scaffold surface) of the 
bone cells. To overcome this restraint, surface coating or 
modification of biocompatible metals presents a way to improve the 
surface biocompatibility [10]. Another limitation of the current metallic 
implants is the possible release of toxic metallic ions and particles 
through corrosion lead to inflammatory cascades and allergic 
reactions, which reduce the biocompatibility and cause tissue loss 
[11]. A proper treatment of the implant surface may help to avoid this 
problem and create a direct bonding with the tissue. Following are 
the few metals widely used in fabrication of implants for tissue 
engineering applications.  
 
Magnesium 
 
     Magnesium alloys are biocompatible and shown promising 
features for use in orthopedic implant. [12]. Significant progress on 
biologically active magnesium stents and orthopedic bones has been 
achieved in recent years. Furthermore, its elevated biodegradability 
eliminates the second surgery for the removal of the scaffold. All 
these facts suggest that Magnesium (Mg) has momentous potential 
as a load-bearing biomaterial [13]. Recently, Mg-Ca alloys are 
produced and evaluated in vitro and in vivo as biodegradable 
biomaterials for orthopedic applications. However, concerns over the 
toxicity of dissolved Mg have been raised due to its rapid dissolution 
in body fluids, but it has been shown that the excess of magnesium 
is efficiently excreted from the body in urine [14]. If we were able to 
control the corrosion in Mg and its alloys by ceramic coating or by 
titanium coating, Mg seems to be more promising for tissue 
engineering applications.   
 
 
 
Fig 3. Biodegradable magnesium stents  
 
Titanium and Titanium alloys 
 
     Very few metals can be safely implanted into human beings. 
The implants must be tough enough to support a variety of loads 
offered to it and also ductile enough to move fluidly. In this regard, an 
extensive research is carried out on titanium (Ti) and its alloys which 
are very much biocompatible with a low rate of infection and rejection 
[15]. In addition, titanium forms a very stable passive layer of TiO2 
on its surface and provides superior biocompatibility by preventing 
the corrosion by body fluids [16, 17]. Even if the passive layer is 
damaged, the layer is immediately rebuilt. 
     Since 1940, alloys of titanium are being tested for use in 
orthopedics and continued to gain attention due to their unique 
properties including high specific strength, light weight, excellent 
corrosion resistance and biocompatibility [18]. The most efficient Ti 
alloys being used are “alumina-coated titanium” (Ti-6Al-4V), ASTM 
F1295 (wrought Ti-6Al-7Nb alloy), ASTM F1713 (wrought Ti-13Nb-
13Zr alloy), etc [19]. On the other hand, Ti and its alloys are not 
ferromagnetic and do not cause harm to the patient on magnetic 
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resonance imaging (MRI) unit. Even though the above discussed 
metallic scaffolds were appropriate for heard tissue engineering, the 
bioactivity of these scaffolds was always uncertain. In order to 
promote these materials as cell carriers in tissue engineering we 
must coat the metallic scaffolds with biologically active materials like 
hydroxyapatite (HA) and other growth factors like fetal bovine serum 
(FBS), etc. (FBS) [20].    
 
 
 
Fig 4. Porous and solid Titanium scaffolds  
 
Nickel- Titanium Alloys (Nitinol) 
 
     Nickel titanium alloys have drawn a lot attention due to their 
mechanical properties like superelasticity or shape memory effects 
(remember its original shape) [21]. Since the elastic modulus and the 
compressive strength of Nickel- Titanium alloys (NiTi) are close to 
that of the bone and due its good biocompatibility, porous NiTi alloys 
have been used in making spinal inter vertebral spacers used in the 
treatment of scoliosis [22]. Extensive in vivo testing results indicate 
that NiTi alloys are highly biocompatible, more than stainless steels 
[23]. Biocompatibility of Nickel titanium alloys and their physical 
properties suggest that this alloy may offer substantial gains in the 
orthopedic field.  
 
 
 
Fig 5. Metallic Hip made up of Nickel- Titanium Alloy   
 
Biodegradable Implants 
 
     To construct an ideal scaffold for tissue engineering, 
biodegradable implants are indisputable candidates for induction in 
to the tissues and dissolve away completely forever [24]. Use of 
biodegradable scaffold has made it easy to sustain the mechanical 
and structural integrity of the system by gradual replacement of 
scaffold with newly formed tissues [25]. Currently biodegradable 
ceramics, polymers, gels and their composites have been used to 
fabricate scaffolds for tissue engineering applications. 
 
Bioceramics 
 
     Thousands of years ago people started using ceramic pottery; 
during last forty years another revolution has accord in the 
application of ceramics to improve the quality of human health. This 
revolution was development of specially fabricated bioceramic 
scaffolds to repair and reconstruction of damaged parts of body. 
Generally bioceramics are synthesized in crystalline and amorphous 
forms and  they are generally classified into two major groups; 
calcium phosphates (CP) and others, including yttria (Y2O3)-
stabilized tetragonal zirconia (ZrO2) (YTZP), alumina (Al2O3) and 
some silicate and phosphate families of glasses and crystallized 
glasses (glass-ceramics) [26]. The most successful class of 
bioceramics belongs to biodegradable CP group, including 
hydroxyapatite (HA) and β-tricalcium phosphate (TCP), they are 
analogous to the inorganic constituents of hard tissues of 
vertebrates. List of medically applicable ceramics are given in the 
tabular column 2.   
 
Table 2. Bioceramics with medical application 
 
Activity  Ceramics Formula 
Bioinert Alumina 
Zirconia  
Al2O3 
ZrO2 
Bioactive  Bioglass 
Hydroxyapatite (high temperature sintered) 
NA2O-CaO-P2O3-SiO 
Ca10(PO4)6(OH)2 
Biodegradable Hydroxyapatite (low temperature sintered) 
Tricalcium Phosphate 
Soluble calcium aluminate 
Ca10(PO4)6(OH)2 
Ca3(PO4)2 
CaO-Al2O3 
 
Hydroxyapatite 
 
     Hydroxyapatite (HA) is chemically similar to the mineral 
constituents of bones and hard tissues in mammals. HA is one 
among few materials classed under biodegradable ceramics, 
meaning it supports bone in growth and osteointegration when used 
in orthopedic, dental and maxillofacial applications [27]. Implanted 
HA surface binds to the natural apatite through body fluids and this 
chemical bonding promotes the bone-implant monosystem. 
Mechanical properties of HA implants can be controlled by varying 
the synthesis and sintering temperatures. Normally the HA implants 
were sintered to increase its mechanical properties, but the implants 
sintered below 8000C shows lesser mechanical properties but grater 
biodegradability in vivo [28].Because HA is stable under in vivo 
conditions, it is often recommended to coat over metallic implants 
(most commonly titanium/titanium alloys and stainless steels) to alter 
the surface properties and make the implant more biologically active. 
In this manner the body sees hydroxyapatite material as truly 
biocompatible happy to accept [29].  
 
 
 
Fig 6. Bioceramic scaffolds made of Hydroxyapatite 
 
β-Tricalcium phosphate  
 
     β -Tricalcium phosphate (β-TCP) is calcium salt of phosphoric 
acid and well known as a biodegradable material demonstrated 
clinical importance. The porous β-TCP bioceramic scaffolds 
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structurally resemble the cancellous bone, whose porous network 
could allow tissue to in growth exhibiting good osteoconductive 
properties. Bone in general consists, by weight of 25% water, 15% 
organic materials and 60% mineral phases [30]. The mineral phase 
consists primarily of calcium and phosphate ions, with traces of 
magnesium, carbonates, etc. as per literature Tricalcium phosphate 
(TCP) has four polymorphs, α β γ and super α. The γ polymorph is 
high pressure phase and the super α polymorph is observed at 
temperatures over 15000C [31]. Therefore the most frequently 
available polymorphs in bioceramics are α and β-TCP and these two 
forms are interchangeable by varying the sintering temperature.    
     However, the pure β-TCP porous scaffold shows weak 
mechanical properties, which limit its application as bone graft [32]. 
In spite of its limitations β-TCP is preferred over HA due to their 
excellent bio-absorbability [33]. Application of biphasic composites 
made up of HA and β-TCP is recommended to fabricate biologically 
active scaffolds with optimum dissolution rate and other advantages 
for better performance. However, the biphasic composites cannot be 
used for load-bearing applications due to their poor mechanical 
properties [34].   
 
 
 
Fig 7. Bioceramic constructs of tricalcium phosphate 
 
Biodegradable Polymers 
 
     In recent years, biodegradable fibers which have diameters in 
nanometer range have attracted great attention, as it is considered 
that the proper in vivo phenotype cannot be consistently achieved if 
cells are presented with fibers with diameters equal to or greater 
than the cell size [35]. Biodegradable polymers offer number of 
advantages over other materials for fabricating scaffolds in 
regenerative medicine. The key advantages include the ability to 
tailor mechanical properties and degradation kinetics of polymers to 
suit various tissue applications. Synthetic polymers are also 
attractive because they can be fabricated into a variety of shapes 
with desired pore morphologic features conducive to tissue in-
growth. Furthermore, polymers can be designed with chemical 
functional groups that can induce tissue in-growth [36]. Polymers 
such as polylactic acid (PLA), polyglycolic acid (PGA), copolymers of 
PLA and PGA (PLGA), polyanhydrides, polyorthoesters, 
polycaprolactones, polycarbonates, and polyfumerates have many 
properties that are well-suited for the purposes of tissue engineering. 
They are non-immunogenic, non-toxic and bioresorbable [37].  
Efforts to find solutions to cure orthopaedic injuries/diseases have 
elucidated the necessity of developing new polymers that meet a 
number of demanding requirements. These requirements differ from 
the ability of scaffold to provide mechanical support during tissue 
growth and gradually degrade the implant to biocompatible products 
to more demanding requirements such as the ability to fit in the live 
cells, growth factors etc and provide osteoconductive and 
osteoinductive environments [38]. Furthermore, the development of 
in-situ polymerizable compositions that can function as cell delivery 
systems in the form of an injectable liquid/paste are becoming 
increasingly attractive in tissue engineering applications [39]. Many 
of the currently available degradable polymers do not fulfill all of 
these requirements and significant chemical changes to their 
structure may be required if they are to be formulated for such 
applications. 
 
 
 
Fig 8. Polylactic acid scaffold 
     
 
     Scaffolds made from synthetic and natural polymers have 
been investigated extensively in regenerative medicine. This polymer 
implants have advantages such as the ability to generate desired 
pore structures, matching size, shape and mechanical properties to 
suit a variety of applications. However, shaping these scaffolds to fit 
cavities with complicated geometries, bonding to the bone tissues 
and incorporating cells and growth factors and requirement of open 
surgery are a few major disadvantages of this approach. A variety of 
polymer materials used in fabrication of tissue constructs are given in 
the tabular column 3.  
 
Table 3. Variety of polymer materials used in tissue engineering applications 
 
 Protein Based Carbohydrate Based Synthetic 
Natural Collagen Hyluronan  
 Fibrin   
Artificial Gelatine Polylactic acid Polymethylmethacrylate 
  Polyglycolic acid Polyethylene 
  Chitosan Polytetrafluoroethylene 
  Agarose Polycarbonate 
  Alginate Polyesterurethane 
   Polybutyric acid 
  
Hydrogels  
 
     Hydrogels are special class of polymers able to absorb large 
amounts of water with in the spaces available between polymeric 
chains. The water holding capacity of the hydrogels arise mainly due 
to the presence of hydrophilic groups such as amino, carboxyl and 
hydroxyl groups in the polymer chains [40]. These hydrogels have 
been used extensively in various biomedical applications like drug 
delivery, cell carriers, wound management and tissue engineering. 
 
 
Fig 9. Novel hydrogels for tissue engineering 
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     Cross linked polymers in hydrogels provide a 3-dimensional 
polymeric network structure to hydrogels. The use of hydrogels for 
tissue engineering applications dates back to 1960 when Wichterle 
and Lim developed crosslinked ‘poly hydroxyethyl methacrylate’ 
(pHEMA) for use in soft contact lenses [41]. A variety of synthetic 
and naturally hydrogels may be used to synthesize implants for 
regenerative medicine. Synthetic materials include poly (ethylene 
oxide) (PEO), poly(vinyl alcohol) (PVA), poly(acrylic acid) (PAA),etc 
are the widely used materials for the scaffold preparation [42]. 
Recently interest is gained for natural materials like agarose, alginate, 
chitosan, collagen, fibrin, gelatin, and hyaluronic acid due to their 
better bioavailability [43]. 
     Hydrogels have many diverse functions in the field of 
regenerative medicine. They are used as space filling agents, as 
delivery vehicles for bioactive molecules and as three-dimensional 
structures that organize cells and present stimuli to direct the 
formation of a desired tissue [44]. Finally, implants of hydrogel are 
being used to transplant cells and to engineer almost every tissue in 
the body including cartilage, bone, and smooth muscle [45]. 
     Application of biologically active hydrogels in tissue 
engineering has gained much importance due to (a) easy to process 
the polymers; (b) easy to tailor the properties of the hydrogels; and 
(c) highly resorbable.  
     Examples of various hydrogels with tissue engineering 
applications are provided below: [46] 
I. Collagen-coated tissue culture inserts are used for growing three- 
dimensional corneal implant, tracheal gland cells etc.  
II. Poly (lactic-co-glycolic acid) (PLGA) polymer foams are seeded 
with preadipocytes for the epithelial cell culture of the breast.  
III. Porous scaffolding (e.g. filter, swatch of nylon, transwell) coated 
with fibrillar collagen, ideally type III collagen mixed with 
fibronectin or with Matrigel are used for the culture of the 
normal mature liver cells (polyploidy liver cells).  
 
Current status of Biomaterials Research 
 
     Over the last two decades the tissue engineering industry and 
regenerative medicine has continued to evolve and it has become 
“credibly new sector” [47]. More recently, there are efforts happening 
to produce artificial extracellular materials that are actually required 
by cells and tissues for their successful clinical setting [48]. Current 
research primarily focused on functionality of biomaterials in vivo, 
most of our knowledge in this notion gained by regular observation of 
clinical symptoms of failed implants. There is a lack of suitable 
technologies for in vivo evaluation of biomaterials in a clinical setting. 
However, by alterations in existing medical devices, we may expect 
to see devices that heal in a physiologically normal manner. Such 
normal healing will pick up the performance of many devices that are 
now vulnerable due to poor healing [49]. 
     Two areas namely tissue engineering and regenerative 
medicine, both in good progress to craft ultimate and rational medical 
devises [50]. Tissue engineering allows replacement of many tissues 
and organs with functional replacements. Tissue-engineering 
advances will rest on advances in biodegradable materials, rapid 
prototyping (RP), stem cell cultures, angiogenesis, and biomimetic 
strategies for synthesis of extracellular matrix. Regenerative 
medicine, permitting in vivo regeneration of whole organs and 
tissues will ultimately replace tissue engineering. Here some of the 
biomaterials applicable at various levels are explained in tabular 
column 4.  
 
 
 
Table 4. List of biomaterials applicable at various levels of regeneration 
 
Tissue/ 
Organ 
Level of Regeneration Organic Material Inorganic 
Material 
Composite 
Materials 
Skin Basically two-dimensional tissue. Culture is relatively straight forward. Collagen, synthetic biodegradable polymers 
(polylactic acid, etc.) 
-- -- 
Cartilage Extracellular matrices have 3-dimensional structures, but there 
are no blood vessels in cartilage tissues. Cartilage cells are tolerant to 
low-oxygen, low-nutrient environment, making it relatively easy to 
perform 3-dementional culture. 
Polysaccharides (collagen, chondroitin sulfate), 
synthetic biodegradable polymers 
(polylactic acid, etc.) 
-- Collagen / 
polysaccharide, 
collagen / 
polysaccharide / 
hydroxyl apatite 
Bone Extracellular matrices have 3-dimensional structures containing blood 
vessels. Difficulty in sustaining cellular activity and function in the 
central porous core. 
Collagen, synthetic biodegradable polymers 
(polylactic acid, etc.) 
Calcium 
phosphate 
(hydroxyl apatite, 
tricalcium 
phosphate. 
 
Biodegradable 
polymers/calcium 
phosphate, 
collagen/calcium 
phosphate 
Liver Almost no extracellular matrices exist. Regeneration is difficult 
because of the extensive vascular networks and large blood flow. 
Hydrophilic polymer (polyethylene glycol, etc.) 
and hydrophobic polymers (coating) for culture 
plates. 
Temperature-responsive culture plate for  
regeneration of 2D liver cell sheet. 
Apatite porous 
media used for 
liver cell culture 
-- 
Capillary 
blood 
vessel 
Regeneration of capillaries is difficult to regenerate because of the 
small tubular structure consisting of 3 different layers, but capillaries 
are necessary for survival of regenerated organs. Vascular 
endothelial cells are the most common target of tissue engineering. 
Patterned culture plates capable of regulating cell 
adhesion. Hydrogel-cell compositions. Synthetic 
biodegradable polymer nanofibers used as 
scaffolds for cell culture. 
-- -- 
 
DISCUSSION 
 
     Now we may recap the information regarding developments in 
clinical expertise and the engineering quality of medical devices 
during the last thirty years has led to considerable success and 
effectiveness of trauma repair and tissue replacement. Today, the 
medical device industry relies on knowledge of materials science, 
engineering and medicine to develop sophisticated replacements for 
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natural tissues. Furthermore, it is vital to know the basic biology of 
the biomaterials, such as in vivo degradation, osseous replacement 
and biocompatibility in order to evaluate their appropriateness for the 
use in regenerative medicine. Biomaterials of current interest are 
divided in to two categories based on their working strategy namely, 
acellular and cellular materials. Materials that can endorse tissue or 
organ formation without cellular components are called acellular 
materials and cellular materials need cells embedded in the matrix to 
guide tissue development. Implants made up of bioinert metals come 
under cellular materials, and require cell seeding for better 
performance. Acellular materials include biodegradable polymers, 
ceramics and hydrogel, which can perform well even in the absence 
cells. In this regard, acellular materials with good biodegradability are 
found to be more sophisticated for the current application. Further 
disadvantageous of metallic implants include need for a second 
surgical procedure for implant removal and surgery is complicated 
resulting from the presence of the implant. The intent of 
biodegradable implants is to offer protected initial fixation strength 
while allowing degradation and replacement by the host tissue. 
Therefore, there is no need for implant removal.  
     When we check biomaterial applications in regenerative 
medicine, not all biomaterials are implanted within the body and 
there are several examples of medical devices that are used external 
to the body but which, nevertheless, come into critical contact with 
the tissues. We have a large variety of biodegradable implants such 
as sutures, staples, tacks, anchors and interference screws to treat 
both external and internal tissue damages. This brief review is to 
focus on current developments and to provide an insight in 
biodegradable implant biology in regenerative medicine. It is not 
astonishing that there are not just a few widely accepted biomaterials 
in clinical practice but rather a whole range of metals and alloys, 
ceramic, polymers, hydrogels, composites and natural materials from 
which selection is made depending on the precise circumstances.       
 
CONCLUSION 
 
     This review on biomaterials/medical devices in tissue 
engineering has attempted to demonstrate the significant progress 
that has been made with the use of advanced materials in the areas 
of regenerative medicine. It is clear that, interactions between cells 
with the scaffolding materials play pivotal role in successful 
designing of tissue engineering constructs. The nature of the scaffold 
can directly affect biological response, ultimately influencing the rate 
and quality of new tissue proliferation. Although a variety of materials 
have been tested as tissue engineering scaffolds, it is not surprising 
that there is still a long way to go before we can readily and 
effectively intervene and correct nature’s mistakes. 
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